Enter the terms you wish to search for.

Uterine & Pelvic Surgery

GYNECARE TVT ABBREVO® Continence System

GYNECARE TVT ABBREVO® Continence System

GYNECARE TVT ABBREVO® Continence System

Description & Specs
ABBREVO

Less mesh, less dissection, same tension-free support130

With GYNECARE TVT ABBREVO System you can be confident that you are delivering consistent effectiveness with less mesh. It provides excellent tension-free support with just 12 cm of mesh. It uses less mesh in the thigh muscles. That means that 84% less mesh is placed in adductor muscles and 38% less mesh overall.120,130

Like a full length obturator sling, GYNECARE TVT ABBREVO System provides sufficient support with the symmetrical bilateral placement of a 12-cm mesh, which reaches 3 key anatomical structures: obturator internus, obturator membrane and obturator externus.130

GYNECARE TVT ABBREVO System is a 12cm transobturator mid-urethral sling used for the treatment of female stress urinary incontinence.

PRODUCT CODE DESCRIPTION EA/BX
TVTOML GYNECARE TVT ABBREVO® 1
Videos & Media

ABBREVO OBTURATOR Cadaver Comparison (16 min 55 sec)

The TVT ABBREVO Dissection Video shows the different anatomic structures that TVT ABBREVO and TVTO passes through.

Science & Technology

Same efficacy, less mesh120

GYNECARE TVT ABBREVO System offers the same effectiveness with less mesh. In a randomized, controlled trial, a modified obturator procedure with a shorter mesh, which is similar to GYNECARE TVT ABBREVO System, delivered the same consistent effectiveness as the full length GYNECARE TVT™ Obturator System Tension-free Support for Incontinence*,120

ABBREVO pie charts

Significantly less post-operative pain*

Patients in the Modified GYNECARE TVT Obturator System group had:†,120

  • Significantly lower incidence and intensity of groin pain on day 0 and day 1.
  • 35% fewer patients experienced groin pain immediately after surgery.
  • At year three no severe groin pain was reported in either group.152

Site References

  • * Demonstrated in a 36-month, single-center randomized, single-blinded prospective trial of 175 women suffering from SUI. They were randomized to GYNECARE TVT Obturator System or a version modified to use a shorter mesh and less dissection. Evaluation included urinary symptoms and QoL questionnaires. Primary outcome measure was the disappearance of subjective and objective SUI at one year. Secondary outcome measures included complication rates and severity of postoperative groin pain assessed using a visual analog scale.
  • Pain was assessed using a visual analog scale (VAS) graded from 0 to 10; 0 corresponds to absence of pain, 10 corresponds to the worst pain. Severe groin pain was defined as VAS≥5. The patients that reported groin pain at 1 year had VAS scores ≤3 in all cases.)